DK1301501T3 - Tocotrienolchinoncykliseringsprodukter med antihyperkolesterolvirkning - Google Patents

Tocotrienolchinoncykliseringsprodukter med antihyperkolesterolvirkning

Info

Publication number
DK1301501T3
DK1301501T3 DK01969391T DK01969391T DK1301501T3 DK 1301501 T3 DK1301501 T3 DK 1301501T3 DK 01969391 T DK01969391 T DK 01969391T DK 01969391 T DK01969391 T DK 01969391T DK 1301501 T3 DK1301501 T3 DK 1301501T3
Authority
DK
Denmark
Prior art keywords
antihypercholesterol
effect
sup
tocotrienol quinone
cyclization products
Prior art date
Application number
DK01969391T
Other languages
Danish (da)
English (en)
Inventor
Kai-Uwe Baldenius
Hartwig Schroeder
Klaus Kraemer
Karin Schein
Rainer Stuermer
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK1301501T3 publication Critical patent/DK1301501T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK01969391T 2000-07-14 2001-07-13 Tocotrienolchinoncykliseringsprodukter med antihyperkolesterolvirkning DK1301501T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034233A DE10034233A1 (de) 2000-07-14 2000-07-14 Tocotrienolchinon-Cyclisierungsprodukte
PCT/EP2001/008163 WO2002006261A1 (fr) 2000-07-14 2001-07-13 Produits de cyclisation de la tocotrienolquinone a effet antihypercholesterol

Publications (1)

Publication Number Publication Date
DK1301501T3 true DK1301501T3 (da) 2004-07-19

Family

ID=7648895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969391T DK1301501T3 (da) 2000-07-14 2001-07-13 Tocotrienolchinoncykliseringsprodukter med antihyperkolesterolvirkning

Country Status (10)

Country Link
US (1) US6977270B2 (fr)
EP (1) EP1301501B1 (fr)
JP (1) JP2004504313A (fr)
CN (1) CN1441793A (fr)
AT (1) ATE263160T1 (fr)
AU (1) AU2001289659A1 (fr)
DE (2) DE10034233A1 (fr)
DK (1) DK1301501T3 (fr)
ES (1) ES2218448T3 (fr)
WO (1) WO2002006261A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120046237A1 (en) * 1998-04-08 2012-02-23 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
EP2471530B1 (fr) 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Produits therapeutiques actifs en reduction-oxydation destines au traitement de maladies mitochondriales et d'autres etats ainsi que la modulation de bio-marqueurs d'energie
PT1933821T (pt) * 2005-09-15 2020-10-15 Ptc Therapeutics Inc Variantes de cauda de terapêuticos redox-ativos para tratamento de doenças mitocondriais e outras condições e modulação de biomarcadores energéticos
CA2635280C (fr) 2006-02-22 2017-12-12 Edison Pharmaceuticals, Inc. Variants a chaines laterales d'agents therapeutiques ayant une activite oxydoreductrice pour le traitement de maladies mitochondriales et d'autres conditions et pour la modulationde biomarqueurs energetiques
WO2010030607A1 (fr) 2008-09-10 2010-03-18 Edison Pharmaceuticals, Inc. Traitement de troubles globaux du développement grâce à des agents thérapeutiques à activité oxydo-réductrice
SI2963006T1 (sl) * 2008-10-28 2019-01-31 Bioelectron Technology Corporation Sestavek vsebujoč alfa-tokotrienol kinon in njegove vmesne povezave
DK2424495T3 (en) 2009-04-28 2018-04-30 Bioelectron Tech Corp TREATMENT OF LEVERS HEREDIC OPTICAL NEUROPATHY AND DOMINANT OPTICAL ATROPHY WITH TOCOTRIENOL QUINONES
CN102647981B (zh) * 2009-08-26 2016-09-28 爱迪生制药有限公司 预防和治疗脑缺血的方法
JP2014520894A (ja) 2011-07-19 2014-08-25 エジソン ファーマシューティカルズ， インコーポレイテッド 非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
US10251861B2 (en) 2012-06-08 2019-04-09 Ohio State Innovation Foundation Methods for treating burn and scar injury using tocotrienol compositions
WO2017106786A1 (fr) 2015-12-16 2017-06-22 Bioelectron Technology Corporation Procédés améliorés pour l'enrichissement en alpha-tocotriénol à partir de compositions de tocol mixtes
WO2017106803A1 (fr) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Dérivés fluoroalkyle, fluoroalcoxy, phénoxy, hétéroaryloxy, alcoxy, et amine 1,4-benzoquinone pour le traitement de troubles du stress oxydatif

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910007523A (ko) * 1989-10-04 1991-05-30 브리스톨-마이어즈 스퀴브 컴페니 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
CA2050514A1 (fr) 1990-09-14 1992-03-15 Bradley C. Pearce Analogues du tocotrienol acyclique dans le traitement de l'hypercholesterolemie et l'hyperlipidemia
CA2096496A1 (fr) 1992-05-29 1993-11-30 Bradley C. Pearce Analogues du tocotrienol acyclique pour le traitement de l'hypercholesterolemie et de l'hyperlipidemie
US5318993A (en) * 1993-04-16 1994-06-07 Bristol-Myers Squibb Company Antihyperlipidemic benzoquinones
EP0669132A1 (fr) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Composition pharmaceutique à la vitamine E et à l'acetylsalicylate pour le traitement et la prévention de l'atherosclerosis
JP3926888B2 (ja) 1997-05-27 2007-06-06 株式会社カネカ コレステロール低下剤

Also Published As

Publication number Publication date
EP1301501A1 (fr) 2003-04-16
WO2002006261A1 (fr) 2002-01-24
DE50101861D1 (de) 2004-05-06
CN1441793A (zh) 2003-09-10
ATE263160T1 (de) 2004-04-15
ES2218448T3 (es) 2004-11-16
DE10034233A1 (de) 2002-01-24
US20040116715A1 (en) 2004-06-17
AU2001289659A1 (en) 2002-01-30
US6977270B2 (en) 2005-12-20
JP2004504313A (ja) 2004-02-12
EP1301501B1 (fr) 2004-03-31

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
GB9801690D0 (en) Therapeutic agents
YU41801A (sh) Derivati fenilglicina
NO20010628L (no) Substituerte oksazol- og thiazolderivater som hPPAR <gamma> og hPPAR <alfa> aktivatorer
AU2002246728A1 (en) Carboline derivatives
AU2002249890A1 (en) Carboline derivatives
NO902301L (no) Fremgangsmaate for fremstilling av diarylstyrylkinolin-disyrer.
DE60121461D1 (de) Kondensierte pyridoindolderivate
IT1285770B1 (it) Composti corticoidei
DK1301501T3 (da) Tocotrienolchinoncykliseringsprodukter med antihyperkolesterolvirkning
DE69214127D1 (de) Überbrückte, cyclische ketale
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE259813T1 (de) Triazolopyrimidinderivate
PT1204659E (pt) Benzofuranos serotoninergicos
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
ATE307103T1 (de) Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK49487A (da) 9-n-substituerede derivater af erythromycylamin til anvendelse imod infektioner med gram-positive bakterier
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
CA2445620A1 (fr) Composes tetracycliques utilises comme inhibiteurs de pde5-
ATE218138T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung